[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 332 Introduced in Senate (IS)]

<DOC>






116th CONGRESS
  1st Session
                                 S. 332

  To amend title 38, United States Code, to remove the manifestation 
    period required for the presumptions of service connection for 
 chloracne, porphyria cutanea tarda, and acute and subacute peripheral 
 neuropathy associated with exposure to certain herbicide agents, and 
                          for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            February 5, 2019

Mr. Blumenthal introduced the following bill; which was read twice and 
             referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL


 
  To amend title 38, United States Code, to remove the manifestation 
    period required for the presumptions of service connection for 
 chloracne, porphyria cutanea tarda, and acute and subacute peripheral 
 neuropathy associated with exposure to certain herbicide agents, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Agent Orange Exposure Fairness Act 
of 2019''.

SEC. 2. REMOVAL OF MANIFESTATION PERIOD REQUIRED FOR PRESUMPTIONS OF 
              SERVICE CONNECTION FOR CERTAIN DISEASES ASSOCIATED WITH 
              EXPOSURE TO CERTAIN HERBICIDE AGENTS.

    Section 1116(a)(2) of title 38, United States Code, is amended--
            (1) in subparagraph (C), by striking ``within one'' and all 
        that follows through ``1975'';
            (2) in subparagraph (E), by striking ``within a'' and all 
        that follows through ``1975''; and
            (3) by adding at the end the following new subparagraph:
            ``(I) Acute and subacute peripheral neuropathy becoming 
        manifest to a degree of disability of 10 percent or more.''.
                                 <all>